아스타잔틴 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 원료별, 용도별, 지역별, 부문별 예측(2026-2033년)

Astaxanthin Market Size, Share & Trends Analysis Report By Product (Oil, Softgel, Liquid, Dried algae meal or Biomass), By Source (Natural, Synthetic), By Application (Cosmetics, Nutraceuticals, Food), By Region, And Segment Forecasts, 2026 - 2033

US $ 5,950 ￦ 8,722,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,188,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 13,120,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

아스타잔틴 시장 개요

세계의 아스타잔틴 시장 규모는 2025년 19억 6,000만 달러로 평가되었고, 2033년 42억 7,000만 달러에 이를 것으로 예측됩니다.

2026-2033년에는 CAGR 9.54%를 나타낼 것으로 전망됩니다. 아스타잔틴 수요 증가는 양식업, 동물사료, 영양보조식품, 화장품, 의약품, 식음료 등 다양한 산업에서의 사용 증가에 지지되고 있습니다.

건강한 생활양식을 위한 영양에 대한 의식이 높아지고, 높은 입원비용을 바탕으로 영양보조식품에 대한 기호 증가가 영양보조식품과 천연 항산화제 수요를 견인할 것으로 예측됩니다. 시장 진출기업은 영양보조식품 수요 증가에 대응하기 위해 생산능력을 대폭 증강하고 있습니다. 예를 들어, 2023년 4월에는 Algalif가 아이슬란드에 건설중인 1만 2,500제곱미터의 지속 가능한 천연 아스타잔틴 생산 시설이 계획대로 진행되고 있다고 발표했습니다. 2021년 여름에 시작된 3,000만 달러 규모의 확대 계획은 2023년 말까지 완전 가동했습니다. 이 대규모 투자는 회사의 사업 확장에 대한 강한 의지를 보여줍니다. 게다가 2022년 4월에는 북경은 살구집단이 지난 2년간 두 번째가 되는 원생지역의 아스타잔틴 농장 생산능력 확대를 발표하여 생산능력을 극대화하였습니다. 알가텍사는 갈조 유래 제품 '후코비탈'의 생산능력을 3배로 확대하여 영양보조식품시장 수요 증가에 대응하고 있습니다.

아스타잔틴 생산량 증가를 위한 첨단 기술의 도입은 시장 성장을 가속할 것으로 기대됩니다. 예를 들어, 2024년 3월에는 Kuehnle AgroSystems(KAS)가 S2G Ventures를 선도 투자자로 삼는 시리즈 A2 자금으로 300만 달러를 확보했습니다. 이 투자는 KAS가 개발한 천연 아스타잔틴 생산의 혁신적인 기법의 상업화를 가속화하기 위한 것입니다. 특허받은 암소 발효 공정을 활용함으로써 KAS는 기존 방법에 비해 고수량·저비용 자원 소비 삭감을 실현하는 솔루션을 기재하고 있습니다. 이 기술 혁신은 합성품에서 천연품으로의 전환을 지원하고 37억 달러 규모 시장(천연적이고 지속가능한 제품에 대한 소비자 취향 증가가 견인)에 대응하는 것입니다.

화학제품의 유해한 영향에 대한 우려 증가와 식품·화장품 부문에 있어서 합성 첨가물의 사용 증가 등이 천연 대체품의 채용 확대를 뒷받침하는 요인이 되고 있습니다. 2024년 8월 Journal of Ovarian Research 잡지에 게재된 설문조사에서는 아스타잔틴(AST)의 보급이 생식보조의료(ART)의 성과 향상에 기여할 가능성이 지적되었습니다. 이 연구는 아스타잔틴이 생식 기관에서 난자의 질을 개선하고 산화 스트레스(OS)를 줄임으로써 생식 건강 촉진에 기여한다는 것을 밝혔습니다. 아스타잔틴이 난자의 질을 높이고 산화 손상을 최소화하는 능력이 입증된 것은 의약품 부문에서의 응용 가능성을 뒷받침합니다. 산화 스트레스는 많은 건강 상태의 주요 요인이기 때문에 아스타크 산틴은 생식 관련 질환 및 기타 산화 스트레스 관련 질병의 치료에보다 광범위한 채택이 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 아스타잔틴 시장의 변수, 동향과 범위

• 시장 계보 전망
  • 상위 시장 전망
  • 관련·부수 시장 전망
• 시장 역학
• 아스타잔틴 시장 분석 툴
  • 산업 분석 : Porter's Five Forces
  • PESTEL 분석
• 태국의 아스타잔틴 수입량 데이터

제4장 아스타잔틴 시장 : 원료별, 추정·동향 분석

• 원료별 시장 점유율(2025년 및 2033년)
• 세계의 아스타잔틴 시장 : 원료별 전망
• 시장 규모와 예측과 동향 분석(2021-2033년)
  • 천연
  • 합성

제5장 아스타잔틴 시장 : 제품별, 추정·동향 분석

• 제품별 시장 점유율(2025년 및 2033년)
• 세계의 아스타잔틴 시장 : 제품별 전망
• 시장 규모와 예측과 동향 분석(2021-2033년)
  • 건조 해조류 분말 또는 바이오매스
  • 오일
  • 소프트젤
  • 액상
  • 기타

제6장 아스타잔틴 시장 : 용도별, 추정·동향 분석

• 용도별 시장 점유율(2025년 및 2033년)
• 세계의 아스타잔틴 시장 : 용도별 전망
• 시장 규모와 예측과 동향 분석(2021-2033년)
  • 영양보조식품
  • 화장품
  • 양식 및 동물사료
  • 식품
  • 기타

제7장 아스타잔틴 시장 : 지역별, 추정·동향 분석

• 지역별 시장 점유율 분석(2025년 및 2033년)
• 지역별 시장 대시보드
• 세계 지역별 시장 개요
• 시장 규모와 예측 동향 분석(2021-2033년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 주요 시장 진출기업에 의한 최근의 동향과 영향 분석
• 기업/경쟁의 분류
• 공급업체 상황
  • 주요 리셀러와 채널 파트너 목록
  • 주요 기업의 시장 점유율 분석(2025년)
  • Algatech Ltd
  • Cyanotech Corporation
  • Algalif Iceland ehf
  • Beijing Gingko Group(BGG)
  • PIVEG, Inc.
  • Fuji Chemical Industries Co., Ltd
  • ENEOS Corporation
  • Atacama Bio Natural Products SA
  • EID-Parry(India) Limited
  • ALGAMO

KTH

영문 목차

영문목차

Astaxanthin Market Summary

The global astaxanthin market size was estimated at USD 1.96 billion in 2025 and is anticipated to reach USD 4.27 billion by 2033, growing at a CAGR of 9.54% from 2026 to 2033. The growing demand for astaxanthin is being fueled by its increasing use in various industries, including aquaculture, animal feed, nutraceuticals, cosmetics, pharmaceuticals, and food and beverages, among others.

The rising awareness about nutrition for a healthy lifestyle and the increasing preference for dietary supplements owing to the high hospitalization cost are projected to drive the demand for nutraceuticals & natural antioxidants. The market players are significantly increasing their production capacities to compete with the growing demand for nutraceutical products. For instance, in April 2023, Algalif announced that its 12,500 m2 sustainable natural astaxanthin production facility in Iceland was progressing as planned. The USD 30 million expansion, initiated in summer 2021, is expected to be fully operational by the end of 2023. This significant investment underscores. Furthermore, in April 2022, Beijing Gingko Group announced a second expansion of its pristine region's astaxanthin farm capacity in the last 2 years, which would maximize its production capacity. Algatech Ltd. increased its production capacity threefold for FucoVital, a product derived from brown algae, to fulfill the increasing demand for the dietary supplements market.

The introduction of advanced technologies to increase astaxanthin production is expected to boost market growth. For instance, in March 2024, Kuehnle AgroSystems (KAS) secured USD 3 million in Series A2 funding, led by S2G Ventures. This investment aims to accelerate the commercialization of KAS's innovative approach to producing natural astaxanthin. Utilizing a patented dark fermentation process, KAS offers a solution that delivers higher yields, lower costs, and reduced resource consumption compared to conventional methods. This advancement supports the shift from synthetic to natural, addressing a market valued at USD 3.7 billion and driven by increasing consumer preference for natural, sustainable products.

Increasing concerns about the adverse effects of chemicals and the growing use of synthetic additives in edible products and topical applications are some of the factors responsible for the increasing adoption of natural alternatives. In August 2024, a study published in the Journal of Ovarian Research highlighted that astaxanthin (AST) supplementation could enhance assisted reproductive technology (ART) outcomes. The research found that AST improves oocyte quality and reduces oxidative stress (OS) in reproductive organs, supporting its role in promoting reproductive health. Astaxanthin's demonstrated ability to enhance oocyte quality and minimize oxidative damage reinforces its potential for pharmaceutical applications. As oxidative stress is a key factor in many health conditions, astaxanthin could see broader adoption in treatments for reproductive and other oxidative stress-related disorders.

Global Astaxanthin Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the astaxanthin market based on source, product, application, and region:

• Source Outlook (Revenue, USD Million, 2021 - 2033)
• Natural
  • Yeast
  • Krill/Shrimp
  • Microalgae
  • Others
• Synthetic
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Dried algae meal or Biomass
• Oil
• Softgel
• Liquid
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Nutraceuticals
• Cosmetics
• Aquaculture and animal Feed
• Food
  • Functional foods and beverages
  • Other traditional food manufacturing applications
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Source
  • 1.2.2. Product
  • 1.2.3. Application
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Source outlook
  • 2.2.2. Product outlook
  • 2.2.3. Application
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Astaxanthin Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing demand for nutraceuticals and natural antioxidants
    • 3.2.1.2. Introduction of advanced technologies
    • 3.2.1.3. Increase in adoption of natural cosmetics, nutraceuticals, and pharmaceuticals.
    • 3.2.1.4. Increased use in aquaculture and coloring of fish
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of production
    • 3.2.2.2. Excess space requirement
• 3.3. Astaxanthin Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
• 3.4. Import Volume Data for Astaxanthin in Thailand (Volume in Metric Tons)

Chapter 4. Astaxanthin Market: Source Estimates & Trend Analysis

• 4.1. Source Market Share, 2025 & 2033
• 4.2. Segment Dashboard
• 4.3. Global Astaxanthin Market by Source Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
  • 4.4.1. Natural
    • 4.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.1.2. Yeast
      • 4.4.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.1.3. Krill/Shrimp
      • 4.4.1.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.1.4. Microalgae
      • 4.4.1.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.1.5. Others
      • 4.4.1.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Synthetic
    • 4.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Astaxanthin Market: Product Estimates & Trend Analysis

• 5.1. Product Market Share, 2025 & 2033
• 5.2. Segment Dashboard
• 5.3. Global Astaxanthin Market by Product Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
  • 5.4.1. Dried algae meal or Biomass
    • 5.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.4.2. Oil
    • 5.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.4.3. Softgel
    • 5.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.4.4. Liquid
    • 5.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.4.5. Others
    • 5.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Astaxanthin Market: Application Estimates & Trend Analysis

• 6.1. Application Market Share, 2025 & 2033
• 6.2. Segment Dashboard
• 6.3. Global Astaxanthin Market by Application Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
  • 6.4.1. Nutraceuticals
    • 6.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.2. Cosmetics
    • 6.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.3. Aquaculture and Animal Feed
    • 6.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.4. Food
    • 6.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.4.2. Functional Food and Beverages
      • 6.4.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.4.3. Other traditional food manufacturing applications
      • 6.4.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.5. Others
    • 6.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Astaxanthin Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2025 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size & Forecasts Trend Analysis, 2021 to 2033:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework/ reimbursement structure
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework/ reimbursement structure
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework/ reimbursement structure
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory framework/ reimbursement structure
    • 7.6.7.3. Competitive scenario
    • 7.6.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory framework/ reimbursement structure
    • 7.6.8.3. Competitive scenario
    • 7.6.8.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework/ reimbursement structure
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory framework/ reimbursement structure
    • 7.7.6.3. Competitive scenario
    • 7.7.6.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework/ reimbursement structure
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework/ reimbursement structure
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Regulatory framework/ reimbursement structure
    • 7.9.1.3. Competitive scenario
    • 7.9.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Regulatory framework/ reimbursement structure
    • 7.9.2.3. Competitive scenario
    • 7.9.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory framework/ reimbursement structure
    • 7.9.3.3. Competitive scenario
    • 7.9.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory framework/ reimbursement structure
    • 7.9.4.3. Competitive scenario
    • 7.9.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2025
  • 8.3.4. Algatech Ltd
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Cyanotech Corporation
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Algalif Iceland ehf
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Beijing Gingko Group (BGG)
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. PIVEG, Inc.
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Fuji Chemical Industries Co., Ltd
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. ENEOS Corporation
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Atacama Bio Natural Products S.A.
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. E.I.D. - Parry (India) Limited
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. ALGAMO
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives

관련자료